Summary
The episode works through why alcohol leaves the body at a roughly constant pace, and why the time needed to clear it grows in proportion to the peak level. Sarah and Kiffer test the Widmark formula by working out the range of estimates its inputs allow, then turn to physical dependence on prescribed benzodiazepines, the role of half-life in tapering, and the confidence interval around the number needed to treat in a Quebec deprescribing trial. A hypothetical calculation shows why the share of opioid-related deaths in which a benzodiazepine is detected cannot measure added risk on its own, and how experimental and case-cohort evidence supply what death data lack. The hosts close by debating the one in a thousand risk threshold behind Canada's Guidance on Alcohol and Health, with a conversion of Australia's guideline into Canadian standard drinks.